Connection

Michael Gold to Prospective Studies

Back to Details
This is a "connection" page, showing publications Michael Gold has written about Prospective Studies.
Michael Gold
Connection Strength
3.521
Prospective Studies
  1. Association of left ventricular remodeling with cardiac resynchronization therapy outcomes. Heart Rhythm. 2023 02; 20(2):173-180.
    View in: PubMed
    Score: 0.120
  2. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial. Circulation. 2021 01 05; 143(1):7-17.
    View in: PubMed
    Score: 0.103
  3. The ECG Belt for CRT response trial: Design and clinical protocol. Pacing Clin Electrophysiol. 2020 10; 43(10):1063-1071.
    View in: PubMed
    Score: 0.102
  4. Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study. Heart Rhythm. 2020 09; 17(9):1566-1574.
    View in: PubMed
    Score: 0.100
  5. The effect of posture, exercise, and atrial pacing on atrioventricular conduction in systolic heart failure. J Cardiovasc Electrophysiol. 2019 12; 30(12):2892-2899.
    View in: PubMed
    Score: 0.097
  6. Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results. Heart Rhythm. 2019 11; 16(11):1636-1644.
    View in: PubMed
    Score: 0.094
  7. The rationale and design of the SMART CRT trial. Pacing Clin Electrophysiol. 2018 09; 41(9):1212-1216.
    View in: PubMed
    Score: 0.089
  8. Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results. Heart Rhythm. 2017 10; 14(10):1456-1463.
    View in: PubMed
    Score: 0.081
  9. Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial. Gynecol Oncol. 2016 Sep; 142(3):413-9.
    View in: PubMed
    Score: 0.077
  10. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study. JACC Heart Fail. 2015 Sep; 3(9):691-700.
    View in: PubMed
    Score: 0.072
  11. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2014 Aug; 11(8):1352-8.
    View in: PubMed
    Score: 0.066
  12. Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices. Am J Cardiol. 2013 Apr 15; 111(8):1165-8.
    View in: PubMed
    Score: 0.061
  13. Comparison of fixed tilt and tuned defibrillation waveforms: the PROMISE study. J Cardiovasc Electrophysiol. 2013 Mar; 24(3):323-7.
    View in: PubMed
    Score: 0.060
  14. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol. 2012 Apr; 23(4):359-66.
    View in: PubMed
    Score: 0.056
  15. The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur Heart J. 2011 Oct; 32(20):2516-24.
    View in: PubMed
    Score: 0.055
  16. Safety and efficacy of low-fluence, high-repetition rate versus high-fluence, low-repetition rate 810-nm diode laser for permanent hair removal--a split-face comparison study. J Cosmet Laser Ther. 2011 Aug; 13(4):134-7.
    View in: PubMed
    Score: 0.054
  17. Temporal stability of defibrillation thresholds with cardiac resynchronization therapy. Heart Rhythm. 2011 Jul; 8(7):1008-13.
    View in: PubMed
    Score: 0.053
  18. A prospective, randomized comparison of the acute hemodynamic effects of biventricular and left ventricular pacing with cardiac resynchronization therapy. Heart Rhythm. 2011 May; 8(5):685-91.
    View in: PubMed
    Score: 0.052
  19. Role of transesophageal echocardiography among patients with atrial fibrillation undergoing electrophysiology testing. Am J Cardiol. 2009 Nov 01; 104(9):1256-8.
    View in: PubMed
    Score: 0.048
  20. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
    View in: PubMed
    Score: 0.045
  21. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation. 2008 Nov 11; 118(20):2022-8.
    View in: PubMed
    Score: 0.045
  22. Optimization of superior vena cava coil position and usage for transvenous defibrillation. Heart Rhythm. 2008 Mar; 5(3):394-9.
    View in: PubMed
    Score: 0.042
  23. Comparison of defibrillation efficacy and survival associated with right versus left pectoral placement for implantable defibrillators. Am J Cardiol. 2007 Jul 15; 100(2):243-6.
    View in: PubMed
    Score: 0.041
  24. A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2007 May; 18(5):490-6.
    View in: PubMed
    Score: 0.040
  25. Rationale and design of a randomized clinical trial to assess the role of overdrive and triggered prevention pacing therapies in reducing atrial fibrillation: the Study of Atrial Fibrillation Reduction (SAFARI). Am Heart J. 2006 Aug; 152(2):231-6.
    View in: PubMed
    Score: 0.039
  26. Effect of an active abdominal pulse generator on defibrillation thresholds with a dual-coil, transvenous ICD lead system. J Cardiovasc Electrophysiol. 2006 Jun; 17(6):617-20.
    View in: PubMed
    Score: 0.038
  27. Coronary sinus electrode does not reduce atrial defibrillation thresholds. Heart Rhythm. 2006 Jun; 3(6):647-52.
    View in: PubMed
    Score: 0.038
  28. Comparison of stimulation sites within left ventricular veins on the acute hemodynamic effects of cardiac resynchronization therapy. Heart Rhythm. 2005 Apr; 2(4):376-81.
    View in: PubMed
    Score: 0.035
  29. Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system. Heart Rhythm. 2005 Jan; 2(1):49-54.
    View in: PubMed
    Score: 0.035
  30. Optimization of atrial defibrillation with a dual-coil, active pectoral lead system. J Cardiovasc Electrophysiol. 2004 Jul; 15(7):790-4.
    View in: PubMed
    Score: 0.033
  31. Comparison of step-down and binary search algorithms for determination of defibrillation threshold in humans. Pacing Clin Electrophysiol. 2004 Feb; 27(2):218-20.
    View in: PubMed
    Score: 0.032
  32. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol. 2004 Feb; 15(2):170-6.
    View in: PubMed
    Score: 0.032
  33. Effect of shock polarity on defibrillation thresholds with a hybrid patch-coil lead system. J Interv Card Electrophysiol. 2003 Dec; 9(3):391-6.
    View in: PubMed
    Score: 0.032
  34. Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol. 2002 Nov; 13(11):1092-7.
    View in: PubMed
    Score: 0.030
  35. Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy. J Am Coll Cardiol. 2022 09 27; 80(13):1205-1216.
    View in: PubMed
    Score: 0.030
  36. Clinical predictors of defibrillation thresholds with an active pectoral pulse generator lead system. Pacing Clin Electrophysiol. 2002 Apr; 25(4 Pt 1):408-13.
    View in: PubMed
    Score: 0.029
  37. Effect of shock polarity on the efficacy of transthoracic atrial defibrillation. Am Heart J. 2002 Mar; 143(3):541-5.
    View in: PubMed
    Score: 0.028
  38. Effects of selective autonomic blockade on T-wave alternans in humans. Circulation. 2002 Feb 19; 105(7):837-42.
    View in: PubMed
    Score: 0.028
  39. The importance of early evaluation after cardiac resynchronization therapy to redefine response: Pooled individual patient analysis from 5 prospective studies. Heart Rhythm. 2022 04; 19(4):595-603.
    View in: PubMed
    Score: 0.028
  40. A new algorithm for transthoracic cardioversion of atrial fibrillation based on body weight. Am J Cardiol. 2001 Nov 01; 88(9):1043-5.
    View in: PubMed
    Score: 0.028
  41. Contrast-enhanced image-guided lead deployment for left bundle branch pacing. Heart Rhythm. 2021 08; 18(8):1318-1325.
    View in: PubMed
    Score: 0.027
  42. Acute Hemodynamic Effects of Cardiac Resynchronization Therapy Versus Alternative Pacing Strategies in Patients With Left Ventricular Assist Devices. J Am Heart Assoc. 2021 03 16; 10(6):e018127.
    View in: PubMed
    Score: 0.027
  43. Modified design of stimulation of the left ventricular endocardium for cardiac resynchronization therapy in nonresponders, previously untreatable and high-risk upgrade patients (SOLVE-CRT) trial. Am Heart J. 2021 05; 235:158-162.
    View in: PubMed
    Score: 0.026
  44. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol. 2000 Dec; 36(7):2247-53.
    View in: PubMed
    Score: 0.026
  45. Effect of second-phase duration on the strength-duration relation for human transvenous defibrillation. Circulation. 2000 Oct 31; 102(18):2239-42.
    View in: PubMed
    Score: 0.026
  46. IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines. J Drugs Dermatol. 2020 10 01; 19(10):985-991.
    View in: PubMed
    Score: 0.026
  47. Permanent His Bundle Pacing Implantation Facilitated by Visualization of the Tricuspid Valve Annulus. Circ Arrhythm Electrophysiol. 2020 10; 13(10):e008370.
    View in: PubMed
    Score: 0.026
  48. Comparison of Left Bundle Branch and His Bundle Pacing in Bradycardia Patients. JACC Clin Electrophysiol. 2020 10; 6(10):1291-1299.
    View in: PubMed
    Score: 0.026
  49. Developmental outcomes following vaccine-proximate febrile seizures in children. Neurology. 2020 07 21; 95(3):e226-e238.
    View in: PubMed
    Score: 0.025
  50. Acute hemodynamic effects of right ventricular pacing site and pacing mode in patients with congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2000 May 01; 85(9):1106-9.
    View in: PubMed
    Score: 0.025
  51. Short term escape rhythm characteristics after radiofrequency ablation of the atrioventricular junction. J Interv Card Electrophysiol. 2000 Apr; 4(1):301-5.
    View in: PubMed
    Score: 0.025
  52. Signal-averaged isoharmonic body surface maps of patients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2000 Feb; 11(2):160-7.
    View in: PubMed
    Score: 0.025
  53. Sensing lead failure in implantable defibrillators: a comparison of two commonly used leads. J Cardiovasc Electrophysiol. 2000 Jan; 11(1):21-4.
    View in: PubMed
    Score: 0.024
  54. Optimization of transvenous coil position for active can defibrillation thresholds. J Cardiovasc Electrophysiol. 2000 Jan; 11(1):25-9.
    View in: PubMed
    Score: 0.024
  55. Evaluation, Management, and Outcomes of Patients Poorly Responsive to Cardiac?Resynchronization Device Therapy. J Am Coll Cardiol. 2019 11 26; 74(21):2588-2603.
    View in: PubMed
    Score: 0.024
  56. Atrial defibrillation with a transvenous lead: a randomized comparison of active can shocking pathways. J Am Coll Cardiol. 1999 Aug; 34(2):358-62.
    View in: PubMed
    Score: 0.024
  57. Comparison of bipolar and integrated sensing for redetection of ventricular fibrillation. Am Heart J. 1999 Jul; 138(1 Pt 1):133-6.
    View in: PubMed
    Score: 0.024
  58. The effect of procainamide on T wave alternans. J Cardiovasc Electrophysiol. 1999 May; 10(5):649-54.
    View in: PubMed
    Score: 0.023
  59. Overdrive atrial pacing for conversion of atrial flutter: comparison of postoperative with nonpostoperative patients. Am Heart J. 1999 Jan; 137(1):100-3.
    View in: PubMed
    Score: 0.023
  60. The effect of shock configuration and delivered energy on defibrillation impedance. Pacing Clin Electrophysiol. 1999 Jan; 22(1 Pt 2):165-8.
    View in: PubMed
    Score: 0.023
  61. A new defibrillator discrimination algorithm utilizing electrogram morphology analysis. Pacing Clin Electrophysiol. 1999 Jan; 22(1 Pt 2):179-82.
    View in: PubMed
    Score: 0.023
  62. Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial). Am Heart J. 2019 05; 211:45-53.
    View in: PubMed
    Score: 0.023
  63. Competitive athletes with implantable cardioverter-defibrillators-How to program? Data from the Implantable Cardioverter-Defibrillator Sports Registry. Heart Rhythm. 2019 04; 16(4):581-587.
    View in: PubMed
    Score: 0.023
  64. Effect of heart rate on T wave alternans. J Cardiovasc Electrophysiol. 1998 Jul; 9(7):703-8.
    View in: PubMed
    Score: 0.022
  65. Comparison of single- and dual-coil active pectoral defibrillation lead systems. J Am Coll Cardiol. 1998 May; 31(6):1391-4.
    View in: PubMed
    Score: 0.022
  66. Effect of shock polarity on biphasic defibrillation thresholds using an active pectoral lead system. J Cardiovasc Electrophysiol. 1998 Apr; 9(4):350-4.
    View in: PubMed
    Score: 0.022
  67. Temporal stability of defibrillation thresholds with an active pectoral lead system. J Cardiovasc Electrophysiol. 1998 Mar; 9(3):240-4.
    View in: PubMed
    Score: 0.022
  68. Strength-duration relationship for human transvenous defibrillation. Circulation. 1997 Nov 18; 96(10):3517-20.
    View in: PubMed
    Score: 0.021
  69. Lead system optimization for transvenous defibrillation. Am J Cardiol. 1997 Nov 01; 80(9):1163-7.
    View in: PubMed
    Score: 0.021
  70. Effect of biphasic waveforms on transvenous defibrillation thresholds in patients with coronary artery disease. Am J Cardiol. 1997 Oct 15; 80(8):1098-100.
    View in: PubMed
    Score: 0.021
  71. Comparison of class Ia/Ib versus class III antiarrhythmic drugs for the suppression of inducible sustained ventricular tachycardia associated with coronary artery disease. Am J Cardiol. 1997 Sep 01; 80(5):591-4.
    View in: PubMed
    Score: 0.021
  72. Biphasic waveforms prevent the chronic rise of defibrillation thresholds with a transvenous lead system. J Am Coll Cardiol. 1997 Jul; 30(1):233-6.
    View in: PubMed
    Score: 0.021
  73. Clinical predictors of transvenous biphasic defibrillation thresholds. Am J Cardiol. 1997 Jun 15; 79(12):1623-7.
    View in: PubMed
    Score: 0.021
  74. The acute hemodynamic effects of right ventricular septal pacing in patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1997 Mar 01; 79(5):679-81.
    View in: PubMed
    Score: 0.020
  75. Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac?Resynchronization: Results From the REVERSE Trial. JACC Heart Fail. 2017 03; 5(3):169-178.
    View in: PubMed
    Score: 0.020
  76. Chronic rise in monophasic defibrillation thresholds with a transvenous lead system. Am J Cardiol. 1997 Feb 15; 79(4):502-5.
    View in: PubMed
    Score: 0.020
  77. Clinical predictors of transvenous defibrillation energy requirements. Am J Cardiol. 1997 Jan 15; 79(2):150-3.
    View in: PubMed
    Score: 0.020
  78. Prospective Internally Controlled Blind Reviewed Clinical Evaluation of Cryolipolysis Combined With Multipolar Radiofrequency andVaripulseTechnology for Enhanced Subject Results in Circumferential Fat Reduction and Skin Laxity of the Flanks. J Drugs Dermatol. 2016 Nov 01; 15(11):1354-1358.
    View in: PubMed
    Score: 0.020
  79. Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. Am J Cardiol. 1996 Sep 01; 78(5):540-3.
    View in: PubMed
    Score: 0.019
  80. Effects of waveform and polarity on defibrillation thresholds in humans using a transvenous lead system. Am J Cardiol. 1996 Aug 01; 78(3):313-6.
    View in: PubMed
    Score: 0.019
  81. Electrophysiologic effects and predictors of success of combination therapy with class Ia and Ib antiarrhythmic drugs for sustained ventricular arrhythmias. Am J Cardiol. 1996 Jul 01; 78(1):47-50.
    View in: PubMed
    Score: 0.019
  82. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol. 1995 Oct; 26(4):967-73.
    View in: PubMed
    Score: 0.018
  83. Acute electrophysiologic effects of amiodarone in patients with congestive heart failure. Am J Cardiol. 1995 Jun 01; 75(16):1158-61.
    View in: PubMed
    Score: 0.018
  84. Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE?Study?and?EFFORTLESS Registry. J Am Coll Cardiol. 2015 Apr 28; 65(16):1605-1615.
    View in: PubMed
    Score: 0.018
  85. Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF). J Card Fail. 2015 Jun; 21(6):479-88.
    View in: PubMed
    Score: 0.018
  86. Overdrive pacing for atrial flutter. Am J Cardiol. 1994 Nov 15; 74(10):1021-3.
    View in: PubMed
    Score: 0.017
  87. Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: a prospective national study. Influenza Other Respir Viruses. 2014 Nov; 8(6):636-45.
    View in: PubMed
    Score: 0.017
  88. Long-term effectiveness of the combined minute ventilation and patient activity sensors as predictor of heart failure events in patients treated with cardiac resynchronization therapy: Results of the Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT device Trial (CLEPSYDRA) study. Eur J Heart Fail. 2014 Jun; 16(6):663-70.
    View in: PubMed
    Score: 0.016
  89. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014 May 27; 129(21):2094-9.
    View in: PubMed
    Score: 0.016
  90. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure. Circ Heart Fail. 2013 Nov; 6(6):1180-9.
    View in: PubMed
    Score: 0.016
  91. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013 Aug 27; 128(9):944-53.
    View in: PubMed
    Score: 0.016
  92. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Eur Heart J. 2013 Sep; 34(33):2592-9.
    View in: PubMed
    Score: 0.015
  93. Ethnic differences in atrial fibrillation identified using implanted cardiac devices. J Cardiovasc Electrophysiol. 2013 Apr; 24(4):381-7.
    View in: PubMed
    Score: 0.015
  94. Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study. Eur J Heart Fail. 2012 Dec; 14(12):1420-8.
    View in: PubMed
    Score: 0.015
  95. Atrial overdrive pacing to prevent atrial fibrillation: insights from ASSERT. Heart Rhythm. 2012 Oct; 9(10):1667-73.
    View in: PubMed
    Score: 0.014
  96. Relevance of electrical remodeling in human atrial fibrillation: results of the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial mechanisms of atrial fibrillation study. Circ Arrhythm Electrophysiol. 2012 Aug 01; 5(4):626-31.
    View in: PubMed
    Score: 0.014
  97. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012 Jan 12; 366(2):120-9.
    View in: PubMed
    Score: 0.014
  98. Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trial. Congest Heart Fail. 2011 Sep-Oct; 17(5):248-54.
    View in: PubMed
    Score: 0.014
  99. Assessment of a novel device-based diagnostic algorithm to monitor patient status in moderate-to-severe heart failure: rationale and design of the CLEPSYDRA study. Eur J Heart Fail. 2010 Dec; 12(12):1363-71.
    View in: PubMed
    Score: 0.013
  100. Do Beta-blockers impact microvolt T-wave alternans testing in patients at risk for ventricular arrhythmias? A meta-analysis. J Cardiovasc Electrophysiol. 2010 Sep; 21(9):1009-14.
    View in: PubMed
    Score: 0.013
  101. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol. 2009 Nov 10; 54(20):1837-46.
    View in: PubMed
    Score: 0.012
  102. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008 Dec 02; 52(23):1834-1843.
    View in: PubMed
    Score: 0.011
  103. Pacing Evaluation-Atrial SUpport Study in Cardiac Resynchronization Therapy (PEGASUS CRT): design and rationale. Am Heart J. 2007 Jan; 153(1):7-13.
    View in: PubMed
    Score: 0.010
  104. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Am Heart J. 2006 Feb; 151(2):288-94.
    View in: PubMed
    Score: 0.009
  105. Efficacy of transthoracic cardioversion of atrial fibrillation using a biphasic, truncated exponential shock waveform at variable initial shock energies. Am J Cardiol. 2004 Dec 15; 94(12):1572-4.
    View in: PubMed
    Score: 0.009
  106. Seasonal variation of mortality in the Antiarrhythmics Versus Implantable Defibrillators (AVID) study registry. Heart Rhythm. 2004 Oct; 1(4):435-40.
    View in: PubMed
    Score: 0.009
  107. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol. 2003 Aug 20; 42(4):627-33.
    View in: PubMed
    Score: 0.008
  108. Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life. Am Heart J. 2003 May; 145(5):841-6.
    View in: PubMed
    Score: 0.008
  109. National study of adverse reactions after vaccination with bacille Calmette-Gu?rin. Clin Infect Dis. 2002 Feb 15; 34(4):447-53.
    View in: PubMed
    Score: 0.007
  110. Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J. 2001 Jan; 141(1):92-8.
    View in: PubMed
    Score: 0.007
  111. Performance of a new steroid-eluting coronary sinus lead designed for left ventricular pacing. Pacing Clin Electrophysiol. 2000 Nov; 23(11 Pt 2):1741-3.
    View in: PubMed
    Score: 0.006
  112. Refusal of out-of-hospital medical care: effect of medical-control physician assertiveness on transport rate. Acad Emerg Med. 1998 Jan; 5(1):4-8.
    View in: PubMed
    Score: 0.005
  113. Gender differences in presentation, management, and cardiac event-free survival in patients with syncope. Am J Cardiol. 1997 Nov 01; 80(9):1183-7.
    View in: PubMed
    Score: 0.005
  114. Use of care and subsequent mortality: the importance of gender. Health Serv Res. 1996 Aug; 31(3):347-63.
    View in: PubMed
    Score: 0.005
  115. Racial differentials in the identification of hypercholesterolemia. J Fam Pract. 1993 Apr; 36(4):425-30.
    View in: PubMed
    Score: 0.004
  116. Hypomagnesemia is a frequent finding in the emergency department in patients with chest pain. Arch Intern Med. 1991 Nov; 151(11):2185-90.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.